ArticleMayo Clinic proceedings. Innovations, quality & outcomes2020
Mobile Mitral and Aortic Valvular Masses in Patients With Hereditary Hemorrhagic Telangiectasia Receiving Intravenous Bevacizumab.
Hasan Ahmad Albitar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.